Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 2
2015 2
2016 1
2019 2
2020 2
2021 3
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Imatinib in COVID-19: hope and caution.
Bernal-Bello D, Morales-Ortega A, Isabel Farfán-Sedano A, de Tena JG, Martín-López JVS. Bernal-Bello D, et al. Among authors: martin lopez jvs. Lancet Respir Med. 2021 Sep;9(9):938-939. doi: 10.1016/S2213-2600(21)00266-6. Epub 2021 Jun 18. Lancet Respir Med. 2021. PMID: 34147143 Free PMC article. No abstract available.
Imatinib for COVID-19: A case report.
Morales-Ortega A, Bernal-Bello D, Llarena-Barroso C, Frutos-Pérez B, Duarte-Millán MÁ, García de Viedma-García V, Farfán-Sedano AI, Canalejo-Castrillero E, Ruiz-Giardín JM, Ruiz-Ruiz J, San Martín-López JV. Morales-Ortega A, et al. Among authors: san martin lopez jv. Clin Immunol. 2020 Sep;218:108518. doi: 10.1016/j.clim.2020.108518. Epub 2020 Jun 27. Clin Immunol. 2020. PMID: 32599278 Free PMC article. No abstract available.
Antibody formation against SARS-CoV-2 in imatinib-treated COVID-19 patients.
Morales-Ortega A, Farfán-Sedano AI, Izquierdo-Martínez A, Llarena-Barroso C, Jaenes-Barrios B, Mesa-Plaza N, Toledano-Macías M, Soria Fernández-Llamazares G, Molina-Esteban L, García de Tena J, Prieto-Menchero S, Gonzalo-Pascua S, San Martín-López JV, Bernal-Bello D. Morales-Ortega A, et al. Among authors: san martin lopez jv. J Infect. 2022 Feb;84(2):248-288. doi: 10.1016/j.jinf.2021.08.034. Epub 2021 Aug 23. J Infect. 2022. PMID: 34437930 Free PMC article. No abstract available.
Diagnosis of bacteraemia and growth times.
Ruiz-Giardín JM, Martin-Díaz RM, Jaqueti-Aroca J, Garcia-Arata I, San Martín-López JV, Sáiz-Sánchez Buitrago M. Ruiz-Giardín JM, et al. Among authors: san martin lopez jv. Int J Infect Dis. 2015 Dec;41:6-10. doi: 10.1016/j.ijid.2015.10.008. Epub 2015 Oct 23. Int J Infect Dis. 2015. PMID: 26482387 Free article.
Early clinical experience with imatinib in COVID-19: Searching for a dual effect.
Morales-Ortega A, Rivas-Prado L, Frutos-Pérez B, Jaenes-Barrios B, Farfán-Sedano AI, García-Parra CJ, Hernández-Muniesa B, Duarte-Millán MÁ, Madroñal-Cerezo E, Ontañón-Nasarre A, Ruiz-Giardín JM, Bermejo F, García-Gil M, Gonzalo-Pascua S, San Martín-López JV, Bernal-Bello D. Morales-Ortega A, et al. Among authors: san martin lopez jv. J Infect. 2021 May;82(5):186-230. doi: 10.1016/j.jinf.2021.02.002. Epub 2021 Feb 5. J Infect. 2021. PMID: 33549625 Free PMC article.
Imatinib might constitute a treatment option for lung involvement in COVID-19.
Bernal-Bello D, Jaenes-Barrios B, Morales-Ortega A, Ruiz-Giardin JM, García-Bermúdez V, Frutos-Pérez B, Farfán-Sedano AI, de Ancos-Aracil C, Bermejo F, García-Gil M, Zapatero-Gaviria A, San Martín-López JV. Bernal-Bello D, et al. Among authors: san martin lopez jv. Autoimmun Rev. 2020 Jul;19(7):102565. doi: 10.1016/j.autrev.2020.102565. Epub 2020 May 3. Autoimmun Rev. 2020. PMID: 32376403 Free PMC article. No abstract available.
Seven Epidemic Waves of COVID-19 in a Hospital in Madrid: Analysis of Severity and Associated Factors.
San Martín-López JV, Mesa N, Bernal-Bello D, Morales-Ortega A, Rivilla M, Guerrero M, Calderón R, Farfán AI, Rivas L, Soria G, Izquierdo A, Madroñal E, Duarte M, Piedrabuena S, Toledano-Macías M, Marrero J, de Ancos C, Frutos B, Cristóbal R, Velázquez L, Mora B, Cuenca P, Satué JÁ, Ayala-Larrañaga I, Carpintero L, Lara C, Llerena ÁR, García V, García de Viedma V, Prieto S, González-Pereira N, Bravo C, Mariño C, Lechuga LA, Tarancón J, Gonzalo S; FUENCOVID Group; Moreno S, Ruiz-Giardin JM. San Martín-López JV, et al. Viruses. 2023 Aug 30;15(9):1839. doi: 10.3390/v15091839. Viruses. 2023. PMID: 37766248 Free PMC article.
Baricitinib or imatinib in hospitalized COVID-19 patients: Results from COVINIB, an exploratory randomized clinical trial.
Morales-Ortega A, Farfán-Sedano AI, San Martín-López JV, Escribá-Bárcena A, Jaenes-Barrios B, Madroñal-Cerezo E, Llarena-Barroso C, Mesa-Plaza N, Frutos-Pérez B, Ruiz-Giardín JM, Duarte-Millán MÁ, Piedrabuena-García SI, Carpintero-García L, Canalejo-Castrillero E, Mora-Hernández B, García-Parra CJ, Magro-García HA, Algaba-García A, Hernández-Muniesa B, Nasarre-López B, Ontañón-Nasarre A, Domínguez-García MJ, Gómez-Santos D, Prieto-Menchero S, García de Tena J, Bermejo F, García-Gil M, Gonzalo-Pascua S, Bernal-Bello D; COVINIB Study Group investigators. Morales-Ortega A, et al. Among authors: san martin lopez jv. J Med Virol. 2023 Feb;95(2):e28495. doi: 10.1002/jmv.28495. J Med Virol. 2023. PMID: 36639911 Clinical Trial.
[Venous thromboembolism in patients with HIV: A case series].
Franco Moreno AI, de Ancos Aracil CL, Cabello Clotet N, San Martín López JV. Franco Moreno AI, et al. Among authors: san martin lopez jv. Enferm Infecc Microbiol Clin. 2012 Apr;30(4):216-7. doi: 10.1016/j.eimc.2011.11.017. Epub 2012 Feb 24. Enferm Infecc Microbiol Clin. 2012. PMID: 22365182 Spanish. No abstract available.
14 results